Skip to main navigation
UroGen Pharma, Ltd logo
  • Who We Are
    • What We Stand For
    • Leadership
    • Advocacy/Unmet Need
    • Work With Us
    • Corporate Responsibility
  • Our Portfolio
    • RTGel® Technology
    • JELMYTO® (mitomycin) for pyelocalyceal solution
    • Partnerships
  • Pipeline
  • Media & Investors
    • Media
    • Investors
      • News Releases
      • Events
      • Financials
      • Governance
      • Stocks
      • Reports
      • Resources
  • Connect

We strive to put patients first and preserve their future possibilities

Investor Relations
  • Overview
  • News Releases
  • Events
  • Financials
  • Governance
  • Stock Info
  • Reports
  • Resources
Event Type Conference Presentation
Jun 13, 2024 11:00 AM EDT
ZUSDURI 12-Month Durability of Response Data Event
Listen to webcast

Upcoming events

There are no upcoming events available at this time.

Past events

There are no past events available at this time.
  • First
  • Previous
  • …
  • Page 6
  • Page 7
  • Current page 8

Presentations

Urogen Corporate Presentation – March 2026
New Horizons in Bladder Cancer: ZUSDURI Duration of Response Results from the ENVISION Study
New Horizons in Bladder Cancer: Insights from Top-Line Data of ATLAS & ENVISION Studies
  • Print this Page
    Print Page
  • Link to Email Alerts page
    Email Alerts
  • Link to RSS page
    RSS Feeds
UroGen Pharma, Ltd logo
  • Who We Are
  • Our Portfolio
  • Pipeline
  • Media
  • Investors
  • Privacy Policy
  • Patent Notice
  • Terms of Use
  • Funding Requests
Follow Us: Linkedin opens in new window Twitter opens in new window
Connect

JELMYTO®, UroGen®, and RTGel® are registered trademarks of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.

© 2026 UroGen Pharma, Ltd All rights reserved

US-UGN-00269 05/24